Empagliflozin after acute myocardial infarction

Among patients hospitalized for acute myocardial infarction and at risk for heart failure, empagliflozin did not lead to a significantly lower risk of a first heart-failure hospitalization or death from any cause than placebo.

Saved in:

Bibliographic Details
Main Authors:	Butler, Javed (Author) , Jones, W. Schuyler (Author) , Udell, Jacob A. (Author) , Anker, Stefan D. (Author) , Petrie, Mark C. (Author) , Harrington, Josephine (Author) , Mattheus, Michaela (Author) , Zwiener, Isabella (Author) , Amir, Offer (Author) , Bahit, M. Cecilia (Author) , Bauersachs, Johann (Author) , Bayes-Genis, Antoni (Author) , Chen, Yundai (Author) , Chopra, Vijay K. (Author) , Figtree, Gemma (Author) , Ge, Junbo (Author) , Goodman, Shaun G. (Author) , Gotcheva, Nina (Author) , Goto, Shinya (Author) , Gasior, Tomasz (Author) , Jamal, Waheed (Author) , Januzzi, James L. (Author) , Jeong, Myung Ho (Author) , Lopatin, Yuri (Author) , Lopes, Renato D. (Author) , Merkely, Béla (Author) , Parikh, Puja B. (Author) , Parkhomenko, Alexander (Author) , Ponikowski, Piotr (Author) , Rossello, Xavier (Author) , Schou, Morten (Author) , Simic, Dragan (Author) , Steg, P. Gabriel (Author) , Szachniewicz, Joanna (Author) , Meer, Peter van der (Author) , Vinereanu, Dragos (Author) , Zieroth, Shelley (Author) , Brückmann, Martina (Author) , Sumin, Mikhail (Author) , Bhatt, Deepak L. (Author) , Hernandez, Adrian F. (Author)
Format:	Article (Journal)
Language:	English
Published:	April 25, 2024
In:	The New England journal of medicine Year: 2024, Volume: 390, Issue: 16, Pages: 1455-1466
ISSN:	1533-4406
DOI:	10.1056/NEJMoa2314051
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa2314051 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/full/10.1056/NEJMoa2314051
Author Notes:	J. Butler, W.S. Jones, J.A. Udell, S.D. Anker, M.C. Petrie, J. Harrington, M. Mattheus, I. Zwiener, O. Amir, M.C. Bahit, J. Bauersachs, A. Bayes‑Genis, Y. Chen, V.K. Chopra, G. Figtree, J. Ge, S.G. Goodman, N. Gotcheva, S. Goto, T. Gasior, W. Jamal, J.L. Januzzi, M.H. Jeong, Y. Lopatin, R.D. Lopes, B. Merkely, P.B. Parikh, A. Parkhomenko, P. Ponikowski, X. Rossello, M. Schou, D. Simic, P.G. Steg, J. Szachniewicz, P. van der Meer, D. Vinereanu, S. Zieroth, M. Brueckmann, M. Sumin, D.L. Bhatt, and A.F. Hernandez

Description
Summary:	Among patients hospitalized for acute myocardial infarction and at risk for heart failure, empagliflozin did not lead to a significantly lower risk of a first heart-failure hospitalization or death from any cause than placebo.
Item Description:	Online veröffentlicht: 6. April 2024 Gesehen am 27.01.2025
Physical Description:	Online Resource
ISSN:	1533-4406
DOI:	10.1056/NEJMoa2314051